Home Dimension Therapeutics

Dimension Therapeutics

acquired
IPO Delisting
Rare Disease Gene Therapy Developer
Basic
Enterprise Profile

Basic Information

Dimension Therapeutics is a gene therapy company focused on developing new treatments for rare diseases. Our team consists of veterans from the biotechnology industry and thought leaders in the fields of gene therapy and rare diseases. The company is committed to advancing a platform of gene therapy programs for rare diseases through clinical development, starting with its leading program in hemophilia, to build a world-class adeno-associated virus (AAV) therapeutic product engine.
Dimension Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2013
info@dimensiontx.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Production of Genetically Engineered Drugs
Technology
Gene Technology Biotechnology
Concept
Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Prescription Drug Cell and Gene Therapy